Regencell Bioscience Holdings Limited (RGC) delivered a return of 529.40% over the past year. Since RGC does not currently pay dividends, the total return equals the price-only return.

A $10,000 investment in Regencell Bioscience Holdings Limited one year ago would be worth $62,940 today, representing a gain of $52,940.

Regencell Bioscience Holdings Limited (RGC) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends. For RGC, the total return equals the price-only return.

Yes, Regencell Bioscience Holdings Limited (RGC) outperformed the S&P 500 by 499.03 percentage points over the past year. RGC delivered a total return of 529.40%, compared to the S&P 500's 30.37%. This 499.03pp alpha means investors in RGC earned more than a passive S&P 500 index fund.

Regencell Bioscience Holdings Limited (RGC) experienced a maximum drawdown of -86.72% over the past year, declining from its peak on 2025-06-17 to its trough on 2025-07-02. The stock has not yet fully recovered to its prior peak. Maximum drawdown measures the worst peak-to-trough decline and is an important risk metric for investors.

Here are Regencell Bioscience Holdings Limited (RGC)'s long-term returns with dividends reinvested. Over 10 years, the total return is 11926.8% (61.4% CAGR) — $10,000 would have grown to $1.20M. Over 20 years: 14011.4% total return (28.1% CAGR) — $10,000 → $1.41M. Over 30 years: 14011.5% total return (17.9% CAGR) — $10,000 → $1.41M. Long-term investors benefit from compounding: dividends buy additional shares, which generate their own dividends, creating an exponential growth effect.

Regencell Bioscience Holdings Limited's best calendar year was 2025 with a total return of 16461.5%. Its worst year was 2023 with a total return of -62.4%. This range shows the volatility investors should expect — the difference between the best and worst year is 16523.9 percentage points.